Skip to main content
Commentary: DMARD types, guselkumab, and interleukin inhibitors in PsA, October 2023
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Commentary: DMARD types, guselkumab, and interleukin inhibitors in PsA, October 2023
User login
Username
Password
Reset your password
Concept
Lead
score
Psoriatic Arthritis
1
1
Anti-Tumor Necrosis Factor (Anti-TNF)
0
0.75
Biologic Therapy
0
0.85
Disease-Modifying Antirheumatic Drugs
0
0.95
Interleukin
0
0.65
Arthritis
0
0.07
Cytokines
0
0.55
Psoriasis
0
0.07
Specialty
Lead
score
Rheumatology
1
1
Pharmacist
0
0.36
Orthopaedics
0
0.12
Edit Tags